SREBP inhibitors: an updated patent review for 2008-present

Zhenyu Peng,Leyuan Chen,Manjiang Wang,Xufan Yue,Feifei Xu,Wenbin Hou,Yiliang Li
DOI: https://doi.org/10.1080/13543776.2023.2291393
2024-01-09
Expert Opinion on Therapeutic Patents
Abstract:Introduction Sterol regulatory element-binding proteins (SREBPs) are a family of membrane-binding transcription factors that activate genes encoding enzymes required for cholesterol and unsaturated fatty acid synthesis. Overactivation of SREBP is related to the occurrence and development of diabetes, nonalcoholic fatty liver, tumor, and other diseases. In the past period, many SREBP inhibitors have been found.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?